https://pipelinereview.com/myovant-sciences-announces-presentation-of-positive-phase-2-data-for-relugolix-in-women-with-heavy-menstrual-bleeding-and-uterine-fibroids-at-the-annual-meeting-of-the-american-congress-of-obstetricia/